BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, December 16, 2025
Home » Topics » Briefs » Other news to note

Other news to note
Other news to note RSS Feed RSS

Other news to note for Oct. 7, 2025

Oct. 7, 2025
Biopharma happenings in Asia-Pacific including deals and partnerships, grants, preclinical data and other news in brief: Amgen, Biocon, Biolinerx, Cell Therapies, Hemispherian, Mitocarex, Scisparc, Teijin
Read More

Other news to note for Oct. 6, 2025

Oct. 6, 2025
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Averto Medical, Nyxoah, Olympus, Owlstone Medical.
Read More

Other news to note for Oct. 6, 2025

Oct. 6, 2025
Biopharma happenings, including deals and partnerships, and other news in brief: Cidara, Dr. Reddy, Esperion, Lava, Rocket, Xoma.
Read More

Other news to note for Oct. 3, 2025

Oct. 3, 2025
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Comphya, Getinge, Johnson & Johnson, Medaxiom, MedHub-AI, Philips, Positron, SS Innovations, U.S. Orthopaedic.
Read More

Other news to note for Oct. 3, 2025

Oct. 3, 2025
Biopharma happenings, including deals and partnerships, and other news in brief: Bolt, Galapagos, Vanda.
Read More

Other news to note for Oct. 2, 2025

Oct. 2, 2025
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Astrazeneca, Remmie, Rapidemic, Rocket Doctor, Thermo Fisher.
Read More

Other news to note for Oct. 2, 2025

Oct. 2, 2025
Biopharma happenings, including deals and partnerships, and other news in brief: Abbvie, Biocon, Biocryst, Boehringer Ingelheim, Cell Therapies, Elektrofi, E-therapeutics, Halozyme, Immedica, Indivior, Innovative Medicines, Leo, Neopharmed, Pharmather, Tangram, Teijin.
Read More

Other news to note for Oct. 1, 2025

Oct. 1, 2025
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Adagio, Avita, Bioretec, Elutia, Gestalt, Illumina, Kardium, Omnipathology, Radiopharm Theranostics, Switchback.
Read More

Other news to note for Oct. 1, 2025

Oct. 1, 2025
Biopharma happenings, including deals and partnerships, and other news in brief: Barinthus, Clywedog, Debiopharm, Faeth, Klotho, Lunai, Mira, Mitocarex, Novavax, Sanofi, Scisparc, Secarna, Skny, Sunrock, Sutro, Turn, Valneva, Veraxa.
Read More

Other news to note for Sept. 30, 2025

Sep. 30, 2025
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Accuray, Aidoc Medical, Alcon, Holberg EEG, Labcorp, Natus, Reflow Medical, Relief Cardiovascular, Roche, Spotitearly, Staar Surgical.
Read More
Previous 1 2 … 8 9 10 11 12 13 14 15 16 … 1381 1382 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 15, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 16, 2025.
  • Novo Nordisk semaglutide pill

    CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials

    BioWorld
    A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
  • Illustration of siRNA structure

    Peptidream reveals milestone in Alnylam collaboration

    BioWorld Science
    Peptidream Inc. has announced a preclinical development milestone in its collaboration with Alnylam Pharmaceuticals Inc. under their siRNA conjugate discovery...
  • Acute myeloid leukemia illustration

    Apollo’s APL-4098 shows potent antileukemic effects

    BioWorld Science
    Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing